Neurofibromatosis Clinical Symposium

20% Off Registration till October 15th!

The 2024 Neurofibromatosis Clinical Updates conference is directed towards healthcare providers that care for neurofibromatosis type 1. As one of the common genetic conditions in pediatrics, almost all healthcare providers will interact with these patients. An awareness and recognition of the condition, as well as potential important complications and associations is important for healthcare providers to be familiar with. Fortunately, in most cases, the management can be done at a primary care level, but it is important for providers to be aware of risk factors and the most up to date information to allow for appropriate monitoring. The conference will highlight the importance of collaboration among healthcare professionals and the significance of monitoring and early intervention of complications to ensure optimal outcome.

Our goal is to improve the knowledge of primary care clinicians, so they are better equipped to provide accurate assessments and management of care, facilitate their interactions with the specialist and improve overall care to this group of patients.

According to The National Early Childhood Technical Assistance Center “Early intervention services can change a child’s developmental path and improve outcomes for children, families, and communities”

Upon conclusion of this program, participants will be able to

• Discuss the critical role of the primary care provider in the lifelong care and management of children and adolescents with neurofibromatosis type 1.
• Assess important clinical signs and symptoms, and the need for intervention and referral to appropriate specialists, as it relates to patient outcomes in this complex disorder.
• Apply best practices and the latest evidence-based guidelines in optimal care and management of neurofibromatosis type 1 patients in the primary clinical practice.
• Recognize potential cancer risks, developmental issues, and other systemic complications of neurofibromatosis type 1.

This course is designed for the primary care provider, advanced practice provider, nursing staff, clinical research scientists and those wanting a better understanding of the presented clinical information.

Phoenix Children’s Conference Center

2632 N. 20th Street

Phoenix, Arizona, 85006

Group 1: $80/ day. Virtual ONLY $45/ day

Group 2: $50/ day. Virtual ONLY $25/ day

Group 3: $24/ day. Virtual ONLY $12/ day

The cost of registration includes: tuition, CME certificate (In-person price includes: lunch, refreshments during the meeting). Net proceeds from this Symposium will go to support Barrow at Phoenix Children’s Neuroscience General Program Fund #1043.

The full fee is payable upon registration.

The Neurofibromatosis Clinical Symposium is an accredited program designed to enhance the practitioner’s knowledge of the significance of early diagnosis and multidisciplinary interventions aiming for holistic care in Cerebral Palsy.

ACCREDITATION/ COURSE CREDIT DESIGNATION STATEMENT

An application has been submitted to The University of Arizona College of Medicine - Tucson and Phoenix Children’s. The University of Arizona College of Medicine - Tucson is accredited by the ACCME to provide continuing medical education for physicians.

Hear from are some of the most respected experts in the field who will provide these crucial updates in the treatment of the complex neuro-patient and how these advances directly relate to the care received from their primary care provider.

Host or Publisher Barrow at Phoenix Children's